title: Subclinical Plasmodium falciparum infection and HIV-1 viral load.
authors.forename: Kimberly C
authors.initials: KC
authors.lastname: Brouwer
authors.forename: Lisa B
authors.initials: LB
authors.lastname: Mirel
authors.forename: Chunfu
authors.initials: C
authors.lastname: Yang
authors.forename: Renu B
authors.initials: RB
authors.lastname: Lal
authors.forename: Margarette S
authors.initials: MS
authors.lastname: Kolczak
authors.forename: Anne M
authors.initials: AM
authors.lastname: Van Eijk
authors.forename: John
authors.initials: J
authors.lastname: Ayisi
authors.forename: Juliana A
authors.initials: JA
authors.lastname: Otieno
authors.forename: Bernard L
authors.initials: BL
authors.lastname: Nahlen
authors.forename: Richard
authors.initials: R
authors.lastname: Steketee
authors.forename: Ya Ping
authors.initials: YP
authors.lastname: Shi
authors.forename: Altaf A
authors.initials: AA
authors.lastname: Lal
mesh_terms: D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D004338:Drug Combinations; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007223:Infant; D007630:Kenya; D016778:Malaria, Falciparum / Q000150:complications* / Q000175:diagnosis* / Q000469:parasitology; D010963:Plasmodium falciparum / Q000502:physiology; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D019562:Viral Load
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine